Gregory M. Sullivan's Insider Trades & SAST Disclosures
Gregory M. Sullivan's most recent trade in Tonix Pharmaceuticals Holding Corp was a trade of 29,017 Stock Option done . Disclosure was reported to the exchange on Feb. 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gregory M. Sullivan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tonix Pharmaceuticals Hold... | Gregory M. Sullivan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 29,017 | 29,017 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Gregory M. Sullivan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 29,017 | 29,017 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Gregory M. Sullivan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 358,000 | 358,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | M. Sullivan Gregory | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 358,000 | 358,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Gregory M. Sullivan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 220,000 | 220,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Gregory M. Sullivan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 220,000 | 220,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Gregory M. Sullivan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,250,000 | 1,250,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Gregory M. Sullivan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,250,000 | 1,250,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Gregory M. Sullivan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,250,000 | 1,250,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Gregory M. Sullivan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,250,000 | 1,250,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Gregory M. Sullivan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 750,000 | 750,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Gregory M. Sullivan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 750,000 | 750,000 | - | - | Stock Option | |
| Tonix Pharmaceuticals Hold... | Gregory M. Sullivan | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.51 per share. | 23 Feb 2021 | 41,322 | 62,727 (0%) | 0% | 0.5 | 21,074 | Common Stock, $0.001 par value |
| Tonix Pharmaceuticals Hold... | Gregory M. Sullivan | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 17 Aug 2020 | 20,000 | 21,405 (0%) | 0% | 1.0 | 20,600 | Common Stock, par value $0.001 |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges